Cancer Moonshot
In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More
News items for the week of Jan. 30, 2023.
President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate
The renewal of the ambitious effort includes the reestablishment of direct White House leadership, with a cross-agency cabinet to drive progress in early detection and care equity.
In a keynote to the AMIA Informatics Summit, the NCI director said precision oncology has created new challenges in data analysis and management.
With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research.
Q&A: Biden Cancer Initiative President Greg Simon Discusses Data Sharing in Precision Oncology
Premium
Standards for interoperability and better cooperation among stakeholders will help unleash the power of genomics in cancer care, says the head of the Biden Cancer Initiative.